Elkridge-based Cel-Sci expands clinical trial sites

Cel-Sci Corp., of Vienna, Va., and Elkridge, said its Taiwanese clinical trial partner, Orient Europharma, has added additional sites in Taiwan in Cel-Sci’s Phase III head and neck cancer clinical trial for Multikine, the company’s flagship investigational immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *